The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis

Abstract

This study demonstrates that the prothrombinase activity of mFGL2 contributes to the pathogenesis of experimental arthritis. These studies may have therapeutic implications for patients with RA.